REPORT ON SUN PHARMACEUTICAL CONTENTS 1. INTRODUCTION 2. GROUP OF COMPANIES 3. FORMULATION OF MANUFACTURING 4. UNIQUE PROFILE OF SUN PHARMACEUTICAL 5. SWOT ANALYSIS 6. PESTLE ANALYSIS 7. PORTER’S FIVE FORCE ANALYSIS 8. FINDINGS & CONCLUSION 9. RECCOMMENDATIONS INTRODUCTION TO THE ORGANISATION Sun Pharmaceuticals was set up in 1983 and the company started off with only 5 products to cure psychiatric illness. Sun Pharma is best known worldwide as the manufacture of specialty Active
Premium Pharmaceutical industry Pharmacology Generic drug
Corporate finance Project Corporate finance Project Sun pharmaceuticals Sun pharmaceuticals Submitted to : Prof. S.Ramesh Submitted by : Shamili.M (FPB1214/125) Submitted to : Prof. S.Ramesh Submitted by : Shamili.M (FPB1214/125) Type | Public | Traded as | BSE : 524715 NSE: sunpharma | Industry | Pharmaceuticals | Founded | 1983
Premium Pharmaceutical industry Pharmacology
com/reports/573951/ Company Analysis - Sun Pharmaceuticals Industries Ltd. Description: "Company Analysis assists individual investors‚ managers and companies in evaluating opportunities‚ trends‚ market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions. The study covers information on the business structure‚ areas of operation‚ products and services offered by the company. It comprises SWOT analysis‚ Key Ratios‚ and financials that
Premium
Highlights: Economic Survey 2012-13 The finance ministry delivered a report on the state of the economy on Wednesday‚ a day before finance minister P Chidambaram unveils what is expected to be the most austere budget in years. The annual report was prepared by Raghuram Rajan‚ the former chief economist to the International Monetary Fund (IMF) who became the top adviser in the finance ministry last year. Following are the highlights of the report: GROWTH * GDP growth seen at 6.1-6.7 pct in 2013/14
Free Economics Macroeconomics Inflation
method to announce something like Veterinary Healthcare supplements by Sun Pharmaceuticals‚ there would be press release on 28th October. Sun Pharmaceuticals decides to expand their focus and are now entering into the Veterinary healthcare sector. Media Briefing A media briefing to be held for journalists from all over India in between press release and press conference. This is basically to give the background about Sun Pharmaceuticals‚ about their R&D in the field of Veterinary health care
Premium Newspaper Medicine Public relations
SUN Pharma Company was established as a partnership firm by Dilip Sanghvi & his family to manufacture pharmaceutical formulations at Vapi‚ Gujarat. The Company specializes in selected therapeutic segment to psychiatry‚ cardiology‚ neurology‚ gastroenterology‚ orthopedics‚ ophthalmology nephrology and diabetology. It also makes Active Pharmaceutical Ingredients such as warfarin‚ carbamazepine‚ etodolac ‚ clorazepate‚ anticancers‚ steroids‚ peptides‚ sex hormones‚ and controlled substances. It is
Premium Pharmacology Pharmacology Ranbaxy Laboratories
b.pharma INTRODUCTION INTRODUCTION Drug Omeprazole Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia‚ peptic ulcer disease (PUD)‚ gastroesophageal reflux disease (GORD/GERD)‚ laryngopharyngeal reflux (LPR)‚ and Zollinger-Ellison syndrome. It was first marketed in the US in 1989 by AstraZeneca under the brand names Losec and Prilosec‚ and is now also available from generic manufacturers under various brand names. AstraZeneca
Premium Pharmaceutical industry Sales Generic drug
participants often use two forecasting techniques‚ Fundamental & Technical analysis. The basic objective of conducting this report is to apply our theoretical knowledge in practical situation. The objective behind conducting this study is as follows: • Quantatives analyze of ten companies. • Qualitative analyze Fundamental Analysis Fundamental analysis is the process of looking at a business at the basic or fundamental financial level. This type of analysis examines key ratios of a business to determine
Premium Stock market P/E ratio Fundamental analysis
STRUCTURE – RATIO ANALYSIS | FINANCIAL MANAGEMENT | GROUP 10 | | MBA (BANKING AND FINANCE) | TERM II | SUBMITTED BY: | DEEPTI SHARMA | DEVANSHU JUNEJA | ROLL NO. : | 067 | 068 | MOBILE NO. : | 07737801787 | 09602869642 | INDIVIDUAL CONTRIBUTION | Undertook entire calculation and analysis for Anuh Pharmacy and Lincoln Pharmacy in addition to part analysis of Dishman Pharmacy and the industry ratios | Undertook entire calculation and analysis for Vivimed Laboratories
Premium Pharmaceutical industry Pharmacology Pharmacy
Analysis of Indian Pharmaceutical Industry Dr. Reddy Laboratories Table of Contents Acknowledgement 4 1. Industry Analysis 5 1.1 Porter’s Five Forces Analysis 5 2. DRL’s Present Strategy 6 2.1Riding on Generics 6 2.2Focusing on depth rather than breadth 7 2.3 Leveraging strategic partnerships to reduce risk and investment 8 2.4 Para IV filings 9 2.5 Focusing on selected therapeutic areas 9 3. Key Issues faced by DRL 10 3.1 Poor positioning in India 10 3.2 Russian Opportunity
Premium Generic drug Pharmaceutical industry